RxDoctor Payments Data

Jamie Wallace, NP

Family · Oswego, NYNPI 1104608595

Payments from drug & device makers

$2,286in general payments, 2019–2025

Across 108 payments — averaging $21.17 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • AbbVie$390
  • AstraZeneca$307
  • Exact Sciences$158
  • Alk-abello, Inc$143
  • Lilly USA, LLC$143
  • Amgen$142
  • plus $1K from 17 others

What the payments were for

  • Food & beverage$2,286100%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

How this compares

$2,286 in reported general payments places this provider in the 85th percentile of 8,883 family providers in New York.

See all family providers in New York

Medicare billing

Part B allowed, 2024
$14,107
Medicare patients
91
Services billed
245

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
Trelegy ElliptaFluticasone/Umeclidin/Vilanter29$19,351
EliquisApixaban19$16,564
FarxigaDapagliflozin Propanediol14$12,161
MounjaroTirzepatide11$11,273
OzempicSemaglutide12$11,032
Albuterol Sulfate HfaAlbuterol Sulfate31$644
Rosuvastatin Calcium29$443
Levothyroxine Sodium41$362
Fluticasone Propionate13$290
Amoxicillin-Clavulanate PotassAmoxicillin/Potassium Clav27$246
Omeprazole17$235
Pantoprazole Sodium18$184
Alprazolam23$183
Bupropion Hcl SrBupropion Hcl15$179
Metoprolol Succinate16$176

Paid to pharmacies, not to this prescriber.

Companies that both paid and supply prescribed drugs

These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.

CompanyPaid to this providerPart D cost of their drugs
GSKTrelegy Ellipta$130$19,35129 claims
PfizerEliquis$70$16,56419 claims
AstraZenecaFarxiga$307$12,16114 claims
Lilly USA, LLCMounjaro$143$11,27311 claims
Novo NordiskOzempic$122$11,03212 claims

Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 85th percentile of 8,883 family providers in New York.

Other family in Oswego

See the full list for New York

Where these figures come from

Is this you, or does something look wrong? →